Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C23H36O3 |
Molecular Weight | 360.5301 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[H][C@@]12CC[C@H](C(C)=O)[C@@]1(C)CC[C@@]3([H])[C@@]2([H])CC[C@@]4([H])C[C@@H](CC[C@]34C)OC(C)=O
InChI
InChIKey=GFHOQCXDABGYAL-MHFBBLOWSA-N
InChI=1S/C23H36O3/c1-14(24)19-7-8-20-18-6-5-16-13-17(26-15(2)25)9-11-22(16,3)21(18)10-12-23(19,20)4/h16-21H,5-13H2,1-4H3/t16-,17+,18-,19+,20-,21-,22-,23+/m0/s1
Molecular Formula | C23H36O3 |
Molecular Weight | 360.5301 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 8 / 8 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/17553499Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/14640542 | https://www.ncbi.nlm.nih.gov/pubmed/27516905
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17553499
Curator's Comment: The description was created based on several sources, including
https://www.ncbi.nlm.nih.gov/pubmed/14640542 | https://www.ncbi.nlm.nih.gov/pubmed/27516905
Allopregnan-3α-ol-20-one acetate (5α-Pregnan-3β-ol-20-one 3β-acetate) is a derivative of neurosteroid Allopregnanolone. Allopregnan-3α-ol-20-one acetate is an allosteric modulator of inhibitory γ-aminobutyric acid (GABA-A) receptors on neural stem cells and other cell types in the brain. Allopregnanolone acetate exerted moderate antidystonic effects and provoked a moderately reduced locomotor activity in animal models. Metabolic transformation of Allopregnan-3α-ol-20-one acetate leads Allopregnanolone. Allopregnanolone is in phase III trials for the treatment of super-refractory status epilepticus (SRSE) and postpartum depression, but Allopregnan-3α-ol-20-one acetate was never tested in clinical trials.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2093872 Sources: https://www.ncbi.nlm.nih.gov/pubmed/17553499 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/17553499
Rat: 15, 30 and 50mg/kg as single i.p. dose.
Route of Administration:
Intraperitoneal
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24012744
GABA-induced current was enhanced by allopregnanolone at concentrations of 0.01 uM and more in guinea-pig adrenal medullary cells.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:25:24 GMT 2023
by
admin
on
Sat Dec 16 08:25:24 GMT 2023
|
Record UNII |
0G0M7A1R8J
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
53835422
Created by
admin on Sat Dec 16 08:25:24 GMT 2023 , Edited by admin on Sat Dec 16 08:25:24 GMT 2023
|
PRIMARY | |||
|
0G0M7A1R8J
Created by
admin on Sat Dec 16 08:25:24 GMT 2023 , Edited by admin on Sat Dec 16 08:25:24 GMT 2023
|
PRIMARY | |||
|
6003-24-3
Created by
admin on Sat Dec 16 08:25:24 GMT 2023 , Edited by admin on Sat Dec 16 08:25:24 GMT 2023
|
PRIMARY |